| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Myocardial Diseases | |||||
| Acquired Immunodeficiency Syndrome | |||||
| HIV Infections | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cardiomyopathies | |||||
| Immunologic Deficiency Syndromes | |||||
| Infection | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Disease | |||||
| Immune System Diseases | |||||
| Lentivirus Infections | |||||
| Pathologic Processes | |||||
| Retroviridae Infections | |||||
| RNA Virus Infections | |||||
| Sexually Transmitted Diseases | |||||
| Sexually Transmitted Diseases, Viral | |||||
| Slow Virus Diseases | |||||
| Virus Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
|
